Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    7935686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
Conditions: Fibrosis;   Focal Glomerulosclerosis;   Kidney Failure;   Nephrotic Syndrome;   Proteinuria
Intervention: Drug: Pirfenidone

Indicates status has not been verified in more than two years